MarketFriction

Link Pharma Chem Ltd

BSE 524748 · Commodity Chemicals
₹26.24 -7.93%
BSE close2026-10-01
Market cap₹11.8 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales6.057.948.038.854.805.346.457.816.296.736.598.77
Expenses6.937.667.128.305.105.236.687.175.956.046.838.32
Operating Profit-0.880.280.910.55-0.300.11-0.230.640.340.69-0.240.45
OPM %-14.55%3.53%11.33%6.21%-6.25%2.06%-3.57%8.19%5.41%10.25%-3.64%5.13%
Other Income-0.030.37-0.010.270.36-0.560.120.210.05-0.200.150.35
Interest0.220.230.190.220.210.210.140.100.130.140.150.14
Depreciation0.260.270.250.240.240.240.240.240.250.250.250.27
Profit before tax-1.390.150.460.36-0.39-0.90-0.490.510.010.10-0.490.39
Tax %-26.62%-46.67%45.65%16.67%-20.51%-24.44%-26.53%21.57%0.00%40.00%-16.33%17.95%
Net Profit-1.020.220.260.30-0.31-0.67-0.350.400.020.07-0.410.32
EPS in Rs-2.300.500.590.68-0.70-1.51-0.790.900.050.16-0.920.72
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales12.3516.1023.5324.5025.4734.8153.5638.7629.9025.4327.4328.38
Expenses12.1613.5620.7522.4822.0531.6750.0236.0430.5525.3025.9827.14
Operating Profit0.192.542.782.023.423.143.542.72-0.650.131.451.24
OPM %1.54%15.78%11.81%8.24%13.43%9.02%6.61%7.02%-2.17%0.51%5.29%4.37%
Other Income2.39-0.430.070.19-0.69-0.150.46-0.150.640.190.200.35
Interest0.910.800.620.390.360.440.450.760.870.780.530.56
Depreciation0.930.830.860.890.930.870.930.921.030.940.981.02
Profit before tax0.740.481.370.931.441.682.620.89-1.91-1.400.140.01
Tax %20.27%54.17%17.52%29.03%34.03%35.12%28.24%26.97%-28.80%-26.43%42.86%
Net Profit0.590.231.130.660.951.081.880.65-1.36-1.030.080.00
EPS in Rs1.330.522.541.492.142.434.231.46-3.06-2.320.180.01
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth8%-5%-11%16%
Compounded Profit Growth7%-42%-48%100%
Stock Price CAGR8%-6%-18%-24%
Return on Equity4%-1%-6%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital4.444.444.444.444.444.444.444.444.444.444.444.44
Reserves3.934.524.165.355.946.998.1210.0310.609.278.228.35
Borrowings10.805.414.732.712.643.563.666.398.769.225.787.31
Other Liabilities7.353.463.814.694.993.989.828.108.663.024.864.87
Total Liabilities26.5217.8317.1417.1918.0118.9726.0428.9632.4625.9523.3024.97
Fixed Assets17.5110.139.579.769.148.818.718.799.009.949.2810.38
CWIP0.000.000.000.010.430.000.000.210.000.000.000.00
Investments0.020.020.030.030.030.030.034.523.642.932.062.47
Other Assets8.997.687.547.398.4110.1317.3015.4419.8213.0811.9612.12
Total Assets26.5217.8317.1417.1918.0118.9726.0428.9632.4625.9523.3024.97
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity5.13-3.912.233.791.362.954.84-1.26-1.71-0.032.692.15
Cash from Investing Activity-3.278.72-0.73-1.15-0.96-1.66-2.16-4.97-0.080.411.53-2.66
Cash from Financing Activity-0.87-5.75-1.48-2.63-0.460.55-0.332.271.61-0.41-4.210.99
Net Cash Flow0.99-0.940.020.00-0.051.852.35-3.95-0.17-0.030.000.48
Free Cash Flow1.844.801.372.630.491.273.13-2.01-2.60-0.862.430.05
CFO/OP-658%-2,005%92%147%77%83%169%-17%-48%-52%2,046%150%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days63.7468.8649.4249.3345.2971.5158.1936.6034.1862.8772.0570.26
Inventory Days125.34277.34285.9796.9692.5460.0451.3547.68209.23135.89166.94170.29
Days Payable94.5981.61202.93124.25108.98110.86140.7045.37112.9038.51101.21110.59
Cash Conversion Cycle94.49264.59132.4722.0528.8520.68-31.1638.90130.51160.24137.78129.96
Working Capital Days-46.92-6.800.2331.6431.4351.4510.4914.1726.745.1315.07-7.05
ROCE %-8.74%-3.64%13.00%15.41%10.34%18.71%14.61%13.16%6.72%-4.79%-3.00%3.48%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters51.49%51.49%51.49%51.49%51.49%51.49%51.49%51.49%51.49%51.49%52.40%52.40%
DIIs0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%
Public48.49%48.50%48.50%48.49%48.49%48.50%48.49%48.50%48.49%48.49%47.59%47.58%
No. of Shareholders6,2126,1326,2006,0836,1516,1816,1606,1126,0906,0636,0206,005

Fundamentals

Market Cap₹ 11.8 Cr.
Current Price₹ 26.6
Book Value₹ 28.8
ROCE3.48 %
ROE0.63 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)16%
Compounded Profit Growth (TTM)100%
Standalone figures.
Valuation
Market capRs 12 Cr
Enterprise valueRs 18 Cr
P/E (TTM)305315898086734080.00x
Price to book0.91x
Price to sales0.41x
EV / EBITDA11.53x
EV / EBIT32.16x
EV / sales0.65x
Price to cash flow5.42x
Earnings yield0.00%
P/E, 3-year average125.78x
P/B, 3-year average1.11x
P/E, 5-year average53.43x
P/B, 5-year average1.13x
Profitability
Operating margin (excl. other income)5.29%
Operating margin (incl. other income)6.02%
EBITDA margin5.60%
Pre-tax margin0.04%
Net profit margin0.00%
Net margin, latest quarter3.65%
ROE0.63%
ROCE3.48%
ROA0.33%
ROE, 3-year average-5.55%
ROCE, 3-year average-1.32%
ROA, 3-year average-2.84%
ROE, 5-year average0.33%
ROCE, 5-year average4.00%
ROA, 5-year average0.09%
ROIC (approx.)1.67%
Tax rate42.86%
Other income / net worth1.56%
Growth
Sales growth (latest year)7.86%
Sales CAGR, 3 years-10.89%
Sales CAGR, 5 years-4.65%
Profit CAGR, 3 years-50.26%
Profit CAGR, 5 years-40.58%
Sales growth QoQ33.08%
Sales growth YoY (latest quarter)12.29%
Profit growth YoY (latest quarter)-20.00%
Per share
EPS (TTM)Rs 0.00
EPS (latest year)Rs 0.18
EPS (latest quarter)Rs 0.72
EPS, 3-year averageRs -1.73
EPS, 5-year averageRs 0.10
Book value per shareRs 28.80
Sales per shareRs 63.91
Cash flow per shareRs 4.84
Free cash flow per shareRs 0.11
Efficiency
Asset turnover1.10x
Fixed asset turnover2.64x
Inventory turnover3.37x
Inventory days108 days
Debtor days70 days
Debtors turnover5.20x
Creditor days111 days
Cash conversion cycle130 days
Working capital days-7 days
Leverage
Total debtRs 7 Cr
Cash and bankRs 1 Cr
Net debtRs 7 Cr
Debt to equity0.57x
Net debt / EBITDA4.20x
Interest coverage1.02x
Owners' fund to total sources51.22%
Debt to assets29.28%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -3 Cr
Cash from Financing Activity (latest year)Rs 1 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs 2 Cr
Cash from ops / profit, 5 years8.36x
Sales to cash flow12.76x
Statement figures
Net sales (TTM)Rs 28 Cr
Net sales (latest year)Rs 27 Cr
Sales (latest quarter)Rs 9 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 2 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 17 Cr
Total expenditure (latest year)Rs 26 Cr
Total income (latest year)Rs 28 Cr
Share capitalRs 4 Cr
ReservesRs 8 Cr
Shareholders' fundsRs 13 Cr
Total assetsRs 25 Cr
Net blockRs 10 Cr
InvestmentsRs 2 Cr
ReceivablesRs 5 Cr
InventoryRs 5 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)0.44
Ownership
Promoter holding52.40% (+0.91 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.91 is at the 23th percentile (median 1.20).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period524748Nifty 50Difference
1 week-8.8%-2.8% -6.0 pts
1 month-6.3%-6.8% +0.5 pts
3 months-0.8%-7.6% +6.9 pts
3 years-45.3%+14.2% -59.5 pts
5 years-28.0%+27.9% -55.9 pts

Red flags

F-score 7 of 8
explainLow interest cover Interest cover 1.3x in 2026
lookProfit leans on other income Other income was 143% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹9 Cr +12.3% vs Jun 2025. Net profit ₹0 Cr -20.0%.

Activity

Compare
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Link Pharma Chem Ltd?

Link Pharma Chem Ltd (524748) has a market capitalisation of Rs 11.8 Cr. at the 2026-10-01 close.

What were Link Pharma Chem Ltd's latest quarterly results?

In the Jun 2026 quarter, Link Pharma Chem Ltd sales was Rs 9 Cr (+12.3% vs Jun 2025) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03